High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.
暂无分享,去创建一个
S. Mori | K. Hirai | H. Yamabe | Y. Sasajima | Y. Kobashi
[1] A. Rickinson,et al. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes , 1992, Journal of virology.
[2] M. Gaffey,et al. Association of Epstein-Barr virus with human neoplasia. , 1992, Pathology annual.
[3] S. Hamilton-Dutoit,et al. Expression of Epstein–Barr virus replicative proteins in aids‐related non‐Hodgkin's lymphoma cells , 1991, The Journal of pathology.
[4] K. Aozasa,et al. Prognostic factors for pleural lymphoma patients. , 1991, Japanese journal of clinical oncology.
[5] L. Young,et al. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man , 1991, The Journal of experimental medicine.
[6] G. Inghirami,et al. Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. , 1990, The American journal of pathology.
[7] E. Kieff,et al. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 , 1990, Journal of virology.
[8] E. Kieff,et al. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1 , 1990, Journal of virology.
[9] T. Kipps,et al. EBV-associated B-cell lymphomas following transfer of human peripheral blood lymphocytes to mice with severe combined immune deficiency. , 1990, Current topics in microbiology and immunology.
[10] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[11] E. Kieff,et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.
[12] K. Aozasa,et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. , 1989, Japanese journal of clinical oncology.
[13] D. Huang,et al. Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. , 1988, The American journal of pathology.
[14] James F. Jones,et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. , 1988, The New England journal of medicine.
[15] K. Aozasa,et al. Non‐Hodgkin's lymphoma of the pleural cavity developing from long‐standing pyothorax , 1987, Cancer.
[16] L. Young,et al. Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.
[17] E. Kieff,et al. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. , 1987, The Journal of general virology.
[18] N. Raab-Traub,et al. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.
[19] D. Saw,et al. Malignant lymphoepithelial lesion of the salivary gland. , 1986, Human pathology.
[20] D. Staunton,et al. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells , 1985, Journal of virology.
[21] Robert Walgate,et al. Proliferation , 1985, Nature.
[22] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[23] I. W. Mclean,et al. PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.